Document Detail

Double-blind evaluation of domperidone in acute vomiting and dyspeptic disorders.
MedLine Citation:
PMID:  7014284     Owner:  NLM     Status:  MEDLINE    
The anti-emetic effects of domperidone were evaluated under double-blind conditions in twenty-four patients with acute vomiting randomly assigned to treatment either with 10 mg i.m. domperidone (six female, five males) or with placebo (seven females, six males). The therapeutic results were better with domperidone and the differences from placebo were statistically significant (p less than 0.02). In a second randomized, crossover, double-blind trial, domperidone (10 mg t.i.d.) evaluated according to a nine-symptom rating scale, in eighteen dyspeptic patients, proved significantly more effective than placebo. The duration of treatment was 6 weeks and the drugs were crossed-over after 3 weeks. The difference between the two groups was most marked during the second phase of the trial. No side-effects were reported.
I Agorastos; N P Zissis; I Kaprinis; G Goulis
Related Documents :
10660974 - The effect of metoclopramide on antral emptying of a semisolid meal in patients with fu...
18451114 - The timing of haloperidol administration does not affect its prophylactic antiemetic ef...
2047064 - Vitamin b6 is effective therapy for nausea and vomiting of pregnancy: a randomized, dou...
16563314 - Symptom priority and course of symptomatology in specialized palliative care.
21572164 - A genome-wide significant linkage for severe depression on chromosome 3: the depression...
19064244 - Self-efficacy in counseling in norwegian chain pharmacies: a cross-sectional study.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Journal of international medical research     Volume:  9     ISSN:  0300-0605     ISO Abbreviation:  J. Int. Med. Res.     Publication Date:  1981  
Date Detail:
Created Date:  1981-07-09     Completed Date:  1981-07-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0346411     Medline TA:  J Int Med Res     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  143-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Benzimidazoles / therapeutic use*
Clinical Trials as Topic
Double-Blind Method
Dyspepsia / drug therapy*
Middle Aged
Piperidines / therapeutic use*
Vomiting / drug therapy*
Reg. No./Substance:
0/Benzimidazoles; 0/Piperidines; 57808-66-9/Domperidone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A double-blind study of dothiepin hydrochloride (Prothiaden) and amitriptyline in out-patients with ...
Next Document:  Pirenzepin in gastric and duodenal ulcer: a double-blind trial.